Mar 31 |
Omega Therapeutics And Novo Nordisk Collaboration: A Cautious 'Buy'
|
Mar 29 |
We Think Omega Therapeutics (NASDAQ:OMGA) Needs To Drive Business Growth Carefully
|
Mar 28 |
Omega Therapeutics GAAP EPS of -$0.37, revenue of $0.98M
|
Mar 28 |
Omega Therapeutics, Inc. (OMGA) Reports Q4 Loss, Tops Revenue Estimates
|
Mar 28 |
Omega Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Strategic Update
|
Mar 6 |
Omega Therapeutics Announces Two Poster Presentations at the American Association for Cancer Research Annual Meeting 2024
|
Jan 26 |
How Is The Market Feeling About Omega Therapeutics?
|
Jan 16 |
Omega Therapeutics: The Next Weight Loss Drug Runner
|
Jan 10 |
Omega Therapeutics: Starting 2024 With A Bang
|
Jan 10 |
The 3 Best Biotech Stocks to Buy in January 2024
|